Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

NCT07057765 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

DLBCL - Diffuse Large B Cell Lymphoma
Markers of Inflammation

Interventions

DRUG: Observational Assessment of Standard R-CHOP Treatment

Sponsor

Ain Shams University